Session Type
Meeting
Search Results for covid
Abstract Number: 89
SHM Converge 2024
Background: With the advent of COVID-19 vaccinations, disparities in vaccination rates across various demographic groups especially in vulnerable population such as HIV positive patients have become an area of concern. Understanding these disparities and their underlying factors can provide essential insights for designing targeted interventions and optimizing vaccine distribution strategies. This study sought to investigate […]
Abstract Number: 90
SHM Converge 2021
Background: Patients with COVID-19 have increased rates of venous thromboembolism, however, there is currently no standardized approach to anticoagulation (AC) therapy particularly with respect to the proper dose of anticoagulation (prophylactic or therapeutic). Many observational studies have shown a mortality benefit in using prophylactic AC for hospitalized patients with COVID-19. A few studies have reported […]
Abstract Number: 93
SHM Converge 2021
Background: The SARS-CoV-2 (COVID-19) outbreak is rapidly spreading worldwide and as a result clinical predictors of disease severity are critical for appropriate management and disposition of patients. An early and accurate risk stratification of COVID-19 patients may have a great impact on their prognosis given rapid patient deterioration and continued need for rationing of treatments. […]
Abstract Number: 94
SHM Converge 2024
Background: Survivors of critical illness, such as acute respiratory distress syndrome (ARDS) requiring invasive mechanical ventilatory support in an intensive care unit (ICU), commonly experience prolonged morbidity in multiple health domains: psychological distress, functional debility, cognitive impairment, and poorer quality of life. This resulting morbidity is now recognized broadly as post-intensive care syndrome (PICS). COVID-19 ICU survivors are at […]
Abstract Number: 95
SHM Converge 2021
Background: Throughout the COVID-19 pandemic, the practice of intubation for hypoxemic respiratory failure secondary to presumed COVID ARDS has shifted from earlier to later intubation at our hospital. Patients are now intubated for respiratory fatigue rather than for only hypoxemia. Timing of intubation has not been associated with change in mortality based on one recent […]
Abstract Number: 96
SHM Converge 2021
Background: The COVID-19 RT-PCR test is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2 virus (8). False negative RT-PCR tests pose a serious challenge as they can lead to diagnosis and treatment delays as well as increased risk of viral transmission in the community (1-10). […]
Abstract Number: 99
SHM Converge 2023
Background: Since the start of the COVID-19 pandemic, racial and ethnic minorities have experienced disparities in infection rates, hospitalization, and death. Monoclonal antibodies (Mab) decrease hospitalization when given to ambulatory non-severe high-risk patients within 10 day of symptom onset. Disparities in care related to Mabs are not well understood. We describe experience from Mab infusion […]
Abstract Number: 99
SHM Converge 2021
Background: On March 7, New York was declared in “State of Emergency”; all Emergency Room and hospital facilities in NYC were overwhelmed by the rapid and high influx of patients with COVID-19 infection. At least 20% of patients with criteria for hospitalization received mechanical ventilation, and the Mortality reached 80% in a time when the […]
Abstract Number: A6
SHM Converge 2022
Background: Obesity increases the risk of severe illness, hospitalizations, and death from most acute illnesses – particularly infectious diseases. (1,2) African American communities have been greatly affected by the COVID-19 pandemic and are disproportionately impacted by the obesity epidemic in this country. (3, 4) However, little is known of their knowledge and attitudes related to […]
Abstract Number: A9
SHM Converge 2022
Background: Elevated proinflammatory cytokines, including IL-6, are associated with significant morbidity and mortality in COVID-19, and it is hypothesized that blocking the inflammatory pathway may prevent disease progression[1]. IL 6 inhibitors were proposed as a treatment option for hospitalized patients to improve patient-centered outcomes[1]. Few studies that investigated the safety of tocilizumab showed heterogeneous results[2,3]. […]